financetom
Business
financetom
/
Business
/
Nvidia Supplier SK Hynix Soars 9% As Mass Production Of Advanced HBM3E Chips Begins Amid Burgeoning AI Demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvidia Supplier SK Hynix Soars 9% As Mass Production Of Advanced HBM3E Chips Begins Amid Burgeoning AI Demand
Oct 3, 2024 1:37 AM

SK Hynix ( HXSCF ) shares soared over 9% on Thursday following the commencement of mass production of their latest high-bandwidth memory chips.

What Happened: The South Korean company has introduced the HBM3E chips, which feature 12 layers and offer 50% more capacity than the previous eight-layer versions.

This development positions SK Hynix ( HXSCF ) ahead in the competitive race to meet the growing demand driven by artificial intelligence advancements.

The company, a primary supplier to NVIDIA Corp ( NVDA ) , plans to deliver these advanced chips to unnamed customers by the end of the year.

Samsung Electronics ( SSNLF ) had previously announced in July that it would supply its HBM3E 12-high units to customers in the latter half of this year. Meanwhile, Micron Technology Inc ( MU ) disclosed earlier this month that it is shipping production-capable HBM3E 12-high units to key industry partners for qualification.

See Also: Micron Q4 Earnings: Revenue, EPS Beat On ‘Robust AI Demand,’ Company Sees ‘Significantly Improved’ Profitability Ahead, Shares Surge

Why It Matters: In recent months, SK Hynix ( HXSCF ) has experienced significant fluctuations in its stock price. Last week, the company’s shares dropped to their lowest level since February after Morgan Stanley downgraded the stock, citing deteriorating memory conditions. This downgrade slashed the target price to 120,000 won from 260,000 won.

Despite this, SK Hynix ( HXSCF ) has been riding a wave of optimism driven by the AI boom. In July, Goldman Sachs and Citigroup predicted further growth for the company, driven by high demand for AI and positive earnings forecasts. Goldman Sachs raised its stock-price target to 290,000 won, while Citigroup increased its prediction to 350,000 won.

Additionally, SK Group, the parent company of SK Hynix ( HXSCF ), announced a massive $56 billion investment in AI and semiconductor technology by 2026. This investment aims to bolster the company’s supply chains for emerging technologies, including high-bandwidth memory chips.

Price Action: SK Hynix ( HXSCF ) is currently trading at 180,100 won, with a surge of 8.95% on Thursday. The stock has gained 26.47% year-to-date, according to data from Benzinga Pro.

Read Next:

General Motors To Lay Off About 1700 Employees Ahead Of Chevrolet Malibu Phase-Out And Re-Tooling For EV Production

Image Via Shutterstock

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
HLS Therapeutics Q3 Loss Narrows
HLS Therapeutics Q3 Loss Narrows
Nov 9, 2024
08:12 AM EST, 11/07/2024 (MT Newswires) -- HLS Therapeutics ( HLTRF ) on Thursday reported a narrower third-quarter loss. The net loss fell to US$4.84 million, or US$0.15 per share, from US$6.9 million, or US$0.21 per share, last year. Revenue fell to US$14.1 million from US$16 million. HLS cut its revenue range to US$56.5-57.2 million from the previous US$58.5-59.7 million....
Viatris' Q3 Earnings, Revenue Decline; 2024 Adjusted EPS Guidance Lowered
Viatris' Q3 Earnings, Revenue Decline; 2024 Adjusted EPS Guidance Lowered
Nov 9, 2024
08:14 AM EST, 11/07/2024 (MT Newswires) -- Viatris ( VTRS ) reported Q3 adjusted earnings Thursday of $0.75 per diluted share, compared with $0.79 a year earlier. Analysts surveyed by Capital IQ expected $0.68. Revenue for the quarter ended Sept. 30 was $3.74 billion, compared with $3.93 billion a year earlier. Analysts surveyed by Capital IQ expected $3.71 billion. For...
US FDA approves Johnson & Johnson's device for heart condition
US FDA approves Johnson & Johnson's device for heart condition
Nov 9, 2024
Nov 7 (Reuters) - The U.S. Food & Drug Administration has approved Johnson & Johnson's ( JNJ ) device for a type of heart condition, the company said on Thursday. ...
Carlyle Group's Q3 Distributable Earnings, Revenue Rise
Carlyle Group's Q3 Distributable Earnings, Revenue Rise
Nov 9, 2024
08:10 AM EST, 11/07/2024 (MT Newswires) -- Carlyle Group ( CG ) reported Q3 after-tax distributable earnings Thursday of $0.95 per diluted share, up from $0.87 a year earlier. Analysts polled by Capital IQ expected $0.89. Total segment revenue for the quarter ended Sept.30 was $895 million, up from $776.6 million a year earlier. Analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved